Use Case
Managing an unplanned post-authorization safety study
-
A marketed product triggers an unplanned or unanticipated post-authorization safety study — often prompted by a regulatory agency inquiry or a safety signal — and the sponsor must move quickly to design, execute, and interpret the study while managing the regulatory conversation and any impact on planned geographic or indication expansion.
-
Regulatory inquiry requiring rapid response
Delayed expansion into new markets or indications while the safety evaluation is underway
Assembling the right evidence-generation approach on a compressed timeline
Coordinating regulatory messaging with the underlying study data
-
ToxStrategies — Toxicological and biological safety assessment tied to the signal, risk evaluation support
EpidStrategies — Study design, data integration and management, statistical analyses, evidence synthesis and interpretation
Suttons Creek — Device-side signal investigation (complaint trending, root cause, design and manufacturing review), agency response strategy, impact assessment on pending expansion filings
-
A coordinated, rapid response to an unplanned safety evaluation that satisfies regulatory expectations without unnecessarily delaying planned market or indication expansion.